Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Research and Markets: Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

[December 03, 2013]

Research and Markets: Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)" report to their offering.

The report titled 'Global Age-Related Macular Degeneration (AMD (News - Alert)) Market: Trends & Opportunities (2013-2018)' provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various countries like the United States, U.K., and Australia.

The report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall AMD market has also been forecasted for the period 2013-2018, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry lie Novartis, Regeneron, Roche and Bayer are profiled.


Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD, late AMD, dry AMD, Wet AMD, etc. Globally, the disease ranks third as a cause of blindness after cataract and glaucoma. The main factor is aging and other risk factors may include the use of tobacco, genetic tendencies, the degree of pigmentation (with light-colored eyes being at higher risk), arterial hypertension, the ultraviolet rays, and consumption of a non-balanced diet. As for the cure of the disease, there is at present no definitive treatment. Palliative treatments which are able to retard the progress of the disease include the use of intravitreous drugs or injections, lasers, dynamic phototherapy and sometimes surgery.

Globally the prevalence of AMD disease is highest in the U.S. followed by the U.K. and Australia. The world's elderly population is the fastest growing age group; this is the main reason for the rising prevalence of AMD. Rising smoking habits and unhealthy diet are the other reasons which will increase the count of AMD affected people in the near future. New types of drugs such as Eylea have come up which is indicated for the treatment of patients with neovascular (wet) age-related macular degeneration and expected to substitute Lucentis and Avastin drugs in the coming years.

Companies Mentioned:

- Bayer

- Novartis

- Regeneron

- Roche

For more information visit

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ InfoTech Spotlight's Homepage ]

blog comments powered by Disqus


Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter